Inventor and CEO
Over 25 years’ experience as team member, leader and manager in the development of medical systems (Biosense Webster, EPD Medical), industrial systems (Scitex, Creo, InkSure), and military systems (Elop). Inventor and co-inventor of over 20 patents in optics, mechanics and electronics. BSc Electronic Engineering, Tel Aviv University; MBA, Bar-Ilan University.
CEO & Managing Partner at NGT3 VC, Board Member
Former CEO and director of Beta-O2 Technologies. Served as CEO of the Technion Entrepreneurial Incubator. Led establishment of and investment in more than 50 companies, including: Prolor Biotech (sold to OPKO, NYSE: OPK), Mazor Robotics (NASDAQ: MZOR), ReWalk (NASDAQ: RWLK), Corindus (NASDAQ: CVRS), Regentis and many others.
CFO and Board Member at NGT3 VC
CFO of over 30 start-up companies since joining NGT3 in 2006, Nizar has hands-on financial management experience at all levels: from seed investment through early and late financial rounds.
Prof. Haim Shirin
Head of Gastroenterology and Liver Disease Institute at Shamir M.C Israel
Dr. Amir Toren
CTO and BD at NGT3 VC, Business Development
Director of Strategy
Prof. Haim Shirin is a graduate "cum laude" of the Medicine Faculty at the Israel Institute of Technology and qualified in 1986. After his gastroenterology residency he did a post-doc fellowship at the Columbia University in New-York. Since 2011 he is the Head of Gastroenterology and Liver Disease Institute at Shamir M.C., in Israel. Prof. Shirin is an associated professor in Tel-Aviv University and published 94 original papers in peer review journals, many of them in high quality and high IF journals, and presented his studies in national and international meetings. Recently, he has been elected as the President of the Israeli Gastroenterology Association.
Over 18 years in executive management positions in the medical device and healthcare industries, including MediWound (R&D manager),
Pluristem (VP BD), and extensive experience in CEO positions
(Coeruleus, JPMed and StarletDerma).
Entrepreneur, inventor and medical device industry executive for past 20 years, having in-depth experience in managing and creating value for medical device companies. Specialized in developing and introducing a wide range of medical technologies to market, strategic planning, strategic collaborating and M&A’s.
In 2009 David established Stimatix GI and serves as its CEO. In 2014, Stimatix assets were acquired by B.Braun. Prior to Stimatix David served as V.P. of R&D Vision Sciences Inc., a N.Y.-based medical device company specializing in flexible endoscopy. Prior to Vision Sciences Inc. he served as COO and R&D leader at CByond (Olympus-Gyrus-ACMI subsidiary) specializing in minimal invasive surgery.
To date, David published 23 patents applications of which 18 been granted.
David holds an MBA from Haifa University and a B.Sc. electrical engineering from Ben-Gurion University of the Negev (honors).
Experienced in prototyping
and manufacturing medical device and
Co-inventor of 2 utility patents and 2 design patents.